News
Stocktwits on MSN50m
Novavax Tops Weekly Retail Buzz Spike Amid FDA Trial Drama, COVID-19 Vaccine Approval Hopes(NVAX) shares jumped nearly 12.6% over the past week, leading to a surge in retail investor chatter following renewed hopes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback